Find doctors, physicians, and healthcare providers who prescribe Montelukast Sodium in Maine. This page lists the top prescribers of Montelukast Sodium based on Medicare Part D data, including the number of claims, patients served, and total drug costs.
What is Montelukast Sodium?
Montelukast sodium chewable tablets are a leukotriene receptor antagonist indicated for: • prevention and chronic treatment of asthma in patients 2 years of age and older ( 1.1 ). • Acute prevention of exercise-induced bronchoconstriction (EIB) in patients 6 years of age and older ( 1.2 ). It belongs to a class of drugs known as leukotriene receptor antagonist.
Total Claims in Maine
34,741
0.3% of all Montelukast Sodium prescriptions nationwide
Data Source: Prescribing data aggregated from the official CMS.gov Medicare Part D Prescribers by Provider and Drug dataset, published by the Centers for Medicare & Medicaid Services. Data Current As Of: 2023 (most recent CMS release). Individual prescriber counts below 11 are suppressed by CMS for patient privacy.